The diagnosis and treatment of chronic insomnia in adults

Sleep

Volumn 28, Issue 9, 2005, Pages 1047-1048

  Vgontzas, Alexandras N ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ANXIETY DISORDER; AROUSAL; BEHAVIOR THERAPY; CHRONIC DISEASE; COGNITIVE THERAPY; DELTA RHYTHM; DEPRESSION; DISEASE ASSOCIATION; DISTRESS SYNDROME; EDITORIAL; EMOTIONAL DISORDER; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSOMNIA; LATENT PERIOD; MALE; MOOD; PRIORITY JOURNAL; REM SLEEP; SIDE EFFECT; SLEEP APNEA SYNDROME; SLEEP DISORDER; SLEEP WAKING CYCLE;

EID: 24644489033     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/28.9.1047     Document Type: Editorial

References (18)

1. Nowell PD, Buysse DJ, Reynolds DF III, et al. Clinical factors contributing to the differential diagnosis of primary insomnia and insomnia related to mental disorders. Am J Psychiatry. 1997;154:1412-6.
2. Bixler EO, Vgontzas AN, Lin H-M, Vela-Bueno A, Kales A. Insomnia in central Pennsylvania. J Psychosom Res. 2002;53:589-92.
3. Vgontzas AN, Bixler EO, Kales EO, Manfredi RL, Tyson K. Validity and clinical utility of sleep laboratory criteria for insomnia. Intern J Neuroscience. 1994;77;11-21.
4. Thase ME. Treatment issues related to sleep and depression. J Clin Psychiatry. 2000;61(suppl 11):46-50.
5. Vgontzas AN, Tsigos C, Bixler EO, et al. Chronic insomnia and activity of the stress system: a preliminary study. J Psychosom Res. 1998;45:21-31.
6. Vgontzas AN, Bixler EO, Lin H-M, et al. Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. J Clin Endocrinol Metab. 2001;86:3787-94.
7. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA. 1992;267:1244-52.
8. Kales A., Kales J. Evaluation and treatment of insomnia. New York: Oxford University Press; 1984.
9. Edinger JD, Work Group Members. Derivation of research diagnostic criteria for insomnia: report of an American Academy of Sleep Medicine Work Group. 2004;27:1567-96.
10. Stepanski E, Zorick F, Roehrs T, Young D, Roth T. Daytime alertness in patients with chronic insomnia compared with asymptomatic control subjects. Sleep. 1988;11:54-60.
11. Merica H, Blois R, Gaillard JM. Spectral characteristics of sleep EEG in chronic insomnia. Eur J Neurosci. 1998;10:1826-34.
12. Perlis ML, Smith MT, Andrews PJ, Orff H, Giles DE. Beta/gamma EEG activity in patients with primary and secondary insomnia and good sleeper controls. Sleep. 2001;24:110-7.
13. Bonnet MH, Arand DL. 24-hour metabolic rate in insomniacs and matched normal sleepers. Sleep. 1995;18:581-8.
14. Nofzinger EA, Buysse DJ, Germain A, Price JC, Miewald JM, Kupfer DJ. Functional neuroimaging evidence for hyperarousal in insomnia. Am J Psychiatry. 2004;161:2126-9.
15. Vgontzas AN, Mastorakos G, Bixler EO, Kales A, Gold PW, Chrousos GP. Sleep deprivation effects on the activity of the hypothalamic-pituitary-adrenal and growth axes: potential clinical implications. J Clin Endocrinol. 1999;51:205-15.
16. Vgontzas AN, Zoumakis E, Bixler EO, et al. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab. 2004;89:2119-26.
17. Vgontzas AN, Bixler EO, Wittman AM, et al.: Middle-aged men show higher sensitivity of their sleep to the arousing effects of corticotropin-releasing hormone than young men: Clinical implications. J Clin Endocrinol Metab. 2001;86:1489-95.
18. Rodenbeck A, Cohrs S, Jordan W, Heuther G, Ruther E, Hajak G. The sleep-improving effects of doxepin are paralleled by a normalized plasma cortisol secretion in primary insomnia. A placebo-controlled, double-blind, randomized, cross-over study followed by an open treatment over 3 weeks. Psychopharmacology. 2003;170:423-8.